Swedish oncology firm Elekta has received approval from China's State Food and Drug Administration (SFDA) for its Elekta Compact linear accelerator.
Compact, a linear accelerator for conventional radiotherapy applications, is designed for countries in need of rapid buildup of additional treatment capacity, according to the Stockholm-based vendor. It's based on a combination of Elekta technology and the product platform developed by Chinese firm BMEI, which Elekta acquired in 2006.
Related Reading
Elekta executive dies, December 15, 2008
Elekta adds Norway install, October 20, 2008
Elekta donates Leksell to Ukraine, September 30, 2008
Elekta extends stereotactic line, posts Q1 results, September 18, 2008
Elekta plans new products for ASTRO, September 16, 2008
Copyright © 2009 AuntMinnie.com
